Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pain Research|February 17, 2025
Using a Two-Steps Clustering and PCA Analysis for Stratified Chronic Non-Cancer Pain Care: A Retrospective Cross-Sectional StudyAna M Peiró, Jordi Barrachina, Mónica Escorial, et al.
Acta Pharmaceutica (Zagreb, Croatia)|June 12, 2023
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differencesJavier Muriel, Mónica Escorial, César Margarit, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 18, 2023
Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational studyJordi Barrachina, César Margarit, Blanca Andreu, et al.
Value in Health Regional Issues|July 9, 2024
Health-Related Quality of Life in Chronic Pain Treated With Tapentadol Versus Oxycodone/Naloxone and Its Determinants: A Real-World, Single-Center Retrospective Cohort Study in SpainAna M Peiró, Anna Grimby-Ekman, Jordi Barrachina, et al.
Frontiers in Pharmacology|June 16, 2023
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differencesJavier Muriel, Jordi Barrachina, Guillermo Del Barco, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype AnalysisPura Ballester, Cristina Espadas, Susana Almenara, et al.
Basic & Clinical Pharmacology & Toxicology|December 15, 2018
Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patientsJavier Muriel, César Margarit, Jordi Barrachina, et al.
Biomedicines|October 27, 2022
Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World StudyJordi Barrachina, Cesar Margarit, Javier Muriel, et al.
The Pharmacogenomics Journal|November 21, 2019
Gender based differences, pharmacogenetics and adverse events in chronic pain managementBeatriz Planelles, César Margarit, María-Del-Mar Inda, et al.
Scientific Reports|June 17, 2022
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic studyJordi Barrachina, Cesar Margarit, Javier Muriel, et al.
Pageof 2